Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
This report updates the 2023-24 recommendations of the Advisory Committee on Immunization Practices (ACIP) concerning the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2022;72[No. RR-2]:1-24). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. Trivalent inactivated influenza vaccines (IIV3s), trivalent recombinant influenza vaccine (RIV3), and trivalent live attenuated influenza vaccine (LAIV3) are expected to be available. All persons should receive an age-appropriate influenza vaccine (i.e., one approved for their age), with the exception that solid organ transplant recipients aged 18 through 64 years who are receiving immunosuppressive medication regimens may receive either high-dose inactivated influenza vaccine (HD-IIV3) or adjuvanted inactivated influenza vaccine (aIIV3) as acceptable options (without a preference over other age-appropriate IIV3s or RIV3). Except for vaccination for adults aged ≥65 years, ACIP makes no preferential recommendation for a specific vaccine when more than one licensed and recommended vaccine is available. ACIP recommends that adults aged ≥65 years preferentially receive any one of the following higher dose or adjuvanted influenza vaccines: trivalent high-dose inactivated influenza vaccine (HD-IIV3), trivalent recombinant influenza vaccine (RIV3), or trivalent adjuvanted inactivated influenza vaccine (aIIV3). If none of these three vaccines is available at an opportunity for vaccine administration, then any other age-appropriate influenza vaccine should be used.Primary updates to this report include the following two topics: the composition of 2024-25 U.S. seasonal influenza vaccines and updated recommendations for vaccination of adult solid organ transplant recipients. First, following a period of no confirmed detections of wild-type influenza B/Yamagata lineage viruses in global surveillance since March 2020, 2024-25 U.S. influenza vaccines will not include an influenza B/Yamagata component. All influenza vaccines available in the United States during the 2024-25 season will be trivalent vaccines containing hemagglutinin derived from 1) an influenza A/Victoria/4897/2022 (H1N1)pdm09-like virus (for egg-based vaccines) or an influenza A/Wisconsin/67/2022 (H1N1)pdm09-like virus (for cell culture-based and recombinant vaccines); 2) an influenza A/Thailand/8/2022 (H3N2)-like virus (for egg-based vaccines) or an influenza A/Massachusetts/18/2022 (H3N2)-like virus (for cell culture-based and recombinant vaccines); and 3) an influenza B/Austria/1359417/2021 (Victoria lineage)-like virus. Second, recommendations for vaccination of adult solid organ transplant recipients have been updated to include HD-IIV3 and aIIV3 as acceptable options for solid organ transplant recipients aged 18 through 64 years who are receiving immunosuppressive medication regimens (without a preference over other age-appropriate IIV3s or RIV3).This report focuses on recommendations for the use of vaccines for the prevention and control of seasonal influenza during the 2024-25 influenza season in the United States. A brief summary of the recommendations and a link to the most recent Background Document containing additional information are available at https://www.cdc.gov/acip-recs/hcp/vaccine-specific/flu.html?CDC_AAref_Val=https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html. These recommendations apply to U.S.-licensed influenza vaccines. Updates and other information are available from CDC's influenza website (https://www.cdc.gov/flu). Vaccination and health care providers should check this site periodically for additional information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 2,076
Self-citation2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Effectiveness of maternal influenza immunization in mothers and infants
Zaman, K., Roy, E., Arifeen, S. E., Rahman, M., Raqib, R., Wilson, E., Omer, S. B., Shahid, N. S., Breiman, R. F., & Steinhoff, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708630 · Cited by 1,227
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Siston, A. M. (2010) · JAMA · doi:10.1001/jama.2010.479 · Cited by 1,034
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
DiazGranados, C. A., Dunning, A. J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., Pollak, R., Christoff, J., Earl, J., Landolfi, V., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315727 · Cited by 876 · cited 1×
“Randomized efficacy studies comparing these vaccines with nonadjuvanted SD-IIVs against laboratory-confirmed influenza outcomes are few in number ( 86 – 88 ) and cover few influenza seasons.”
The Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Shefer, A. M., & Atkinson, W. W. (2011) · Cited by 665
Influenza vaccination of pregnant women and protection of their infants
Madhi, S. A., Cutland, C. L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., Adrian, P. V., van Niekerk, N., Treurnicht, F., Ortiz, J. R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401480 · Cited by 556
Pearson, M. L., Bridges, C. B., & Harper, S. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e506932006-001 · Cited by 529
(2011) · PubMed · Cited by 424
IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
BARKER, W. H., & MULLOOLY, J. P. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113052 · Cited by 370
Rolfes, M. A., Foppa, I. M., Garg, S., Flannery, B., Brammer, L., Singleton, J. A., Burns, E., Jernigan, D., Olsen, S. J., Bresee, J., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12486 · Cited by 310
Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young Infants
Eick, A. A., Uyeki, T. M., Klimov, A., Hall, H., Reid, R., Santosham, M., & O’Brien, K. L. (2011) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.192 · Cited by 302
Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season
Rolfes, M. A., Flannery, B., Chung, J. R., O’Halloran, A., Garg, S., Belongia, E. A., Gaglani, M., Zimmerman, R. K., Jackson, M. L., Monto, A. S., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz075 · Cited by 297
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Dunkle, L. M., Izikson, R., Patriarca, P., Goldenthal, K. L., Muse, D., Callahan, J., & Cox, M. M. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608862 · Cited by 291
Barker, W. H. (1986) · American Journal of Public Health · doi:10.2105/ajph.76.7.761 · Cited by 290
Tapia, M. D., Sow, S. O., Tamboura, B., Tégueté, I., Pasetti, M. F., Kodio, M., Onwuchekwa, U., Tennant, S. M., Blackwelder, W. C., Coulibaly, F., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30054-8 · Cited by 245
Influenza- and RSV-associated hospitalizations among adults
Mullooly, J. P., Bridges, C. B., Thompson, W. W., Chen, J., Weintraub, E., Jackson, L. A., Black, S., & Shay, D. K. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.09.041 · Cited by 235
Steinhoff, M. C., Katz, J., Englund, J. A., Khatry, S. K., Shrestha, L., Kuypers, J., Stewart, L., Mullany, L. C., Chu, H. Y., LeClerq, S. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30252-9 · Cited by 227
Kissling, E., Valenciano, M., Larrauri, A., Oroszi, B., Cohen, J. M., Nunes, B., Pitigoi, D., Rizzo, C., Rebolledo, J., Paradowska-Stankiewicz, I., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20390-en · Cited by 195
Ferdinands, J. M., Fry, A. M., Reynolds, S., Petrie, J. G., Flannery, B., Jackson, M. L., & Belongia, E. A. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw816 · Cited by 195
Self-citationNeuzil, K. M., Jackson, L. A., Nelson, J., Klimov, A., Cox, N., Bridges, C. B., Dunn, J., DeStefano, F., & Shay, D. (2006) · The Journal of Infectious Diseases · doi:10.1086/507309 · Cited by 191
The Burden of Influenza in Young Children, 2004–2009
Poehling, K. A., Edwards, K. M., Griffin, M. R., Szilagyi, P. G., Staat, M. A., Iwane, M. K., Snively, B. M., Suerken, C. K., Hall, C. B., Weinberg, G. A., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1255 · Cited by 183
Ritzwoller, D. P., Bridges, C. B., Shetterly, S., Yamasaki, K., Kolczak, M., & France, E. K. (2005) · Pediatrics · doi:10.1542/peds.2005-0049 · Cited by 182
Izurieta, H. S., Thadani, N., Shay, D. K., Lu, Y., Maurer, A., Foppa, I. M., Franks, R., Pratt, D., Forshee, R. A., MaCurdy, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71087-4 · Cited by 181
Grohskopf, L. A., Blanton, L., Ferdinands, J. M., Chung, J. R., Broder, K. R., & Talbot, H. K. (2023) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7202a1 · Cited by 175
Self-citationPebody, R. G., Andrews, N., McMenamin, J., Durnall, H., Ellis, J., Thompson, C. I., Robertson, C., Cottrell, S., Smyth, B., Zambon, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20389-en · Cited by 163
Izurieta, H. S., Chillarige, Y., Kelman, J., Wei, Y., Lu, Y., Xu, W., Lu, M., Pratt, D., Chu, S., Wernecke, M., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy716 · Cited by 163
Seasonal influenza vaccine in immunocompromised persons
Bosaeed, M., & Kumar, D. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1445446 · Cited by 158
Young, B. E., Sadarangani, S. P., Jiang, L., Wilder‐Smith, A., & Chen, M. I.-C. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix632 · Cited by 157
Castilla, J., Martínez-Baz, I., Martínez-Artola, V, Reina, G., Pozo, F., García Cenoz, M., Guevara, M., Moran, J., Irisarri, F., Arriazu, M., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20388-en · Cited by 156
McMillan, M., Porritt, K. A., Kralik, D., Costi, L., & Marshall, H. S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.068 · Cited by 155
Belongia, E. A., Sundaram, M. E., McClure, D. L., Meece, J. K., Ferdinands, J. M., & VanWormer, J. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.052 · Cited by 152
Self-citationColeman, B. L., Fadel, S. A., Fitzpatrick, T., & Thomas, S.-M. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12504 · Cited by 145
Bratton, K. N., Wardle, M. T., Orenstein, W. A., & Omer, S. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu915 · Cited by 143
Influenza Virus Infection in Travelers to Tropical and Subtropical Countries
Mutsch, M., Tavernini, M., Marx, A., Gregory, V., Lin, Y. P., Hay, A. J., Tschopp, A., & Steffen, R. (2005) · Clinical Infectious Diseases · doi:10.1086/429243 · Cited by 137
Eisenberg, K. W., Szilagyi, P. G., Fairbrother, G., Griffin, M. R., Staat, M., Shone, L. P., Weinberg, G. A., Hall, C. B., Poehling, K. A., Edwards, K. M., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-3304 · Cited by 131
Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
Allison, M. A., Daley, M. F., Crane, L. A., Barrow, J. C., Beaty, B. L., Allred, N. J., Berman, S., & Kempe, A. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.036 · Cited by 130
Kissling, E., Nunes, B., Robertson, C., Valenciano, M., Reuss, A., Larrauri, A., Cohen, J. M., Oroszi, B., Rizzo, C., Machado, A., et al. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.16.30201 · Cited by 127
Paget, J., Caini, S., Riccio, M. D., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.39.2200753 · Cited by 122
Pasternak, B., Svanstrom, H., Molgaard-Nielsen, D., Krause, T. G., Emborg, H.-D., Melbye, M., & Hviid, A. (2012) · BMJ · doi:10.1136/bmj.e2794 · Cited by 121
Intraseason Waning of Influenza Vaccine Effectiveness
Ray, G. T., Lewis, N., Klein, N. P., Daley, M. F., Wang, S. V., Kulldorff, M., & Fireman, B. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy770 · Cited by 118
Chambers, C., Johnson, D., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.097 · Cited by 115
Donahue, J. G., Kieke, B. A., King, J. P., Destefano, F. R., Mascola, M. A., Irving, S. A., Cheetham, T. C., Glanz, J. M., Jackson, L. A., Klein, N. P., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.069 · Cited by 112
Shay, D. K., Chillarige, Y., Kelman, J. A., Forshee, R. A., Foppa, I., Wernecke, M., Lu, Y., Ferdinands, J. M., Iyengar, A., Fry, A. M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw641 · Cited by 108
Self-citationSafety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
Heikkinen, T., Young, J., van Beek, E., Franke, H. R., Verstraeten, T., Weil, J., & Cioppa, G. D. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.07.007 · Cited by 104
Egg-allergic patients can be safely vaccinated against influenza
Roches, A. D., Paradis, L. P., Gagnon, R., Lemire, C., Bégin, P., Carr, S., Chan, E. S., Paradis, J., Frenette, L., Ouakki, M., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.046 · Cited by 94
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019
Izurieta, H. S., Chillarige, Y., Kelman, J. A., Wei, Y., Lu, Y., Xu, W., Lu, M., Pratt, D., Wernecke, M., MaCurdy, T. E., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa080 · Cited by 93
Izurieta, H. S., Lu, M., Kelman, J. A., Lu, Y., Lindaas, A., Loc, J., Pratt, D., Wei, Y., Chillarige, Y., Wernecke, M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1727 · Cited by 92
Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion
Irving, S. A., Kieke, B. A., Donahue, J. G., Mascola, M. A., Baggs, J., DeStefano, F., Cheetham, T. C., Jackson, L. A., Naleway, A. L., Glanz, J. M., et al. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318279f56f · Cited by 89
A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy
Oppermann, M., Fritzsche, J., Weber‐Schoendorfer, C., Keller‐Stanislawski, B., Allignol, A., Meister, R., & Schaefer, C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.081 · Cited by 84
Fragaszy, E., Warren‐Gash, C., White, P. J., Zambon, M. C. F. A., Edmunds, W. J., Nguyen‐Van‐Tam, J. S., Hayward, A. C., & on behalf of the Flu Watch Group (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12506 · Cited by 83
Chambers, C., Johnson, D. L., Xu, R., Luo, Y. J., Louik, C., Mitchell, A. A., Schatz, M. X., & Jones, K. L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.054 · Cited by 81
Large Summertime Influenza A Outbreak among Tourists in Alaska and the Yukon Territory
Uyeki, T. M., Zane, S. B., Bodnar, U. R., Fielding, K., Buxton, J. A., Miller, J. M., Beller, M. J., Butler, J. C., Fukuda, K., Maloney, S. A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374053 · Cited by 76
Young‐Xu, Y., van Aalst, R., Mahmud, S. M., Rothman, K. J., Snider, J. T., Westreich, D. J., Mor, V., Gravenstein, S., Lee, J. K. H., Thommes, E. W., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy088 · Cited by 75
Richardson, D. M., Medvedeva, E. L., Roberts, C. B., & Linkin, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ261 · Cited by 68
Keitel, W., Treanor, J. J., Sahly, H. M. E., Gilbert, A., Meyer, A. L., PATRIARCA, P. A., & Cox, M. M. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.037 · Cited by 64
Ferdinands, J. M., Gaglani, M., Martin, E. T., Monto, A. S., Middleton, D. B., Silveira, F. P., Talbot, H. K., Zimmerman, R. K., & Patel, M. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab045 · Cited by 62
Self-citationvan Aalst, R., Gravenstein, S., Mor, V., Mahmud, S. M., Wilschut, J., Postma, M. J., & Chit, A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.105 · Cited by 61
The impact of influenza infection on young children, their family and the health care system
Willis, G. A., Preen, D. B., Richmond, P., Jacoby, P. A., Effler, P. V., Smith, D. W., Robins, C., Borland, M. L., Levy, A., Keil, A. D., et al. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12604 · Cited by 59
Donahue, J. G., Kieke, B. A., King, J. P., Mascola, M. A., Shimabukuro, T. T., DeStefano, F., Hanson, K. E., McClure, D. L., Olaiya, O., Glanz, J. M., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.035 · Cited by 59 · cited 1×
“However, in a larger VSD follow-up study, IIV was not associated with an increased risk for miscarriage during the 2012–13, 2013–14, and 2014–15 seasons, regardless of previous season vaccination ( 78 ).”
Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015
Puig-Barberà, J., Mira-Iglesias, A., Tortajada-Girbés, M., López-Labrador, F. X., Librero-López, J., Díez-Domingo, J., Carballido-Fernández, M., Carratalá-Munuera, C., Correcher-Medina, P., Gil-Guillén, V., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.035 · Cited by 58
Radin, J. M., Hawksworth, A. W., Myers, C. A., Ricketts, M. N., Hansen, E. A., & Brice, G. T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.034 · Cited by 55
Ferdinands, J. M., Alyanak, E., Reed, C., & Fry, A. M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz452 · Cited by 55
Self-citationInfluenza and Workplace Productivity Loss in Working Adults
Wormer, J. J. V., King, J. P., Gajewski, A., McLean, H. Q., & Belongia, E. A. (2017) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001120 · Cited by 54
Sammon, C., Snowball, J. M., McGrogan, A., & de Vries, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051734 · Cited by 52
Pelton, S. I., Divino, V. M., Shah, D., Mould-Quevedo, J. F., DeKoven, M., Krishnarajah, G., & Postma, M. J. (2020) · Vaccines · doi:10.3390/vaccines8030446 · Cited by 49
Millman, A. J., Duong, K. K., Lafond, K. E., Green, N. M., Lippold, S. A., & Jhung, M. A. (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12215 · Cited by 47
Ratnam, I., Black, J., Leder, K. S., Biggs, B., Gordon, I., Matchett, E., Padiglione, A. A., Woolley, I. J., Karapanagiotidis, T., Gherardin, T., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.01.008 · Cited by 40
Young‐Xu, Y., Snider, J. T., van Aalst, R., Mahmud, S. M., Thommes, E. W., Lee, J. K. H., Greenberg, D. P., & Chit, A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.063 · Cited by 36
Lu, Y., Chillarige, Y., Izurieta, H. S., Wei, Y., Xu, W., Lu, M., Sung, H.-M., Lindaas, A., Wernecke, M., MaCurdy, T. E., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz360 · Cited by 33
ACOG Committee Statement No. 7: Influenza in Pregnancy: Prevention and Treatment
(2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005479 · Cited by 33
Huang, W., Tang, F.-W., Yang, S.-E., Chih, Y.-C., & Chuang, J.-H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.054 · Cited by 31
Pelton, S. I., Divino, V. M., Postma, M. J., Shah, D., Mould-Quevedo, J. F., DeKoven, M., & Krishnarajah, G. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.054 · Cited by 31
Levin, M. J., Buchwald, U. K., Gardner, J. E., Martin, J. C., Stek, J. E., Brown, E., & Popmihajlov, Z. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.029 · Cited by 27
Prospective Cohort Study of the Safety of an Influenza A(H1N1) Vaccine in Pregnant Chinese Women
Ma, F., Zhang, L., Jiang, R., Zhang, J., Wang, H., Gao, X., Li, X., & Liu, Y. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00375-14 · Cited by 24
Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness
Young, B. E., Mak, T. M., Ang, L. W., Sadarangani, S. P., Ho, H. J. A., Wilder‐Smith, A., Barkham, T., & Chen, M. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820002952 · Cited by 21
Lu, Y., Chillarige, Y., Izurieta, H. S., Wei, Y., Xu, W., Lu, M., Sung, H.-M., Lindaas, A., Wernecke, M., MaCurdy, T. E., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz463 · Cited by 20
Hu, W., Sjoberg, P. A., Fries, A. C., DeMarcus, L. S., & Robbins, A. S. (2022) · Vaccines · doi:10.3390/vaccines10060888 · Cited by 20
Regan, A. K., Fielding, J., Chilver, M. B.-N., Carville, K. S., Minney-Smith, C. A., Grant, K. A., Thomson, C., Hahesy, T., Deng, Y., Stocks, N., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.02.027 · Cited by 19
Domnich, A., Orsi, A., Signori, A., Chironna, M., Manini, I., Napoli, C., Rizzo, C., Panatto, D., & Icardi, G. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2024.2331073 · Cited by 16
Ng, Y., Nandar, K., Chua, L. A. V., Mak, T. M., Foo, K., Muhammad, I. R., Low, C. K. K., Ma, S., Ooi, S. P. L., Lin, R. T. P., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.03.054 · Cited by 15
Chung, H., Campitelli, M. A., Buchan, S. A., Campigotto, A. J., Crowcroft, N. S., Gubbay, J. B., Jung, J. K. H., Karnauchow, T., Katz, K. C., McGeer, A., et al. (2024) · Eurosurveillance · doi:10.2807/1560-7917.es.2024.29.8.2300239 · Cited by 13
Young‐Xu, Y., Snider, J. T., Mahmud, S. M., Russo, E. M., van Aalst, R., Thommes, E. W., Lee, J. K. H., & Chit, A. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.19.1900401 · Cited by 12
Uemura, K., Ono, S., Michihata, N., Yamana, H., & Yasunaga, H. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.03.066 · Cited by 12
Mira‐Iglesias, A., López‐Labrador, F. X., García‐Rubio, J., Mengual‐Chuliá, B., Tortajada‐Girbés, M., Mollar‐Maseres, J., Carballido‐Fernández, M., Schwarz‐Chavarri, G., Puig‐Barberà, J., & Díez‐Domingo, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031129 · Cited by 11
Robinson, C., van Boxmeer, J., Tilson, H. H., Scialli, A. R., Vanchiere, J. A., Ides, E., Sawlwin, D. C., Molrine, D. C., Hohenboken, M. J., Edelman, J. M., et al. (2022) · Vaccines · doi:10.3390/vaccines10101600 · Cited by 10
Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis
Smith, K. J., France, G., Nowalk, M. P., Raviotta, J. M., DePasse, J. V., Wateska, A. R., Shim, E., & Zimmerman, R. K. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.11.015 · Cited by 7
Cited by
Zhu, Y., Wu, J., Hou, L., Liu, X., Zhu, X., Xia, W., Wang, N., Zhao, Y., Zhao, G., & Song, P. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2716519
Metadata
- Authors
- Grohskopf, L. A., Ferdinands, J. M., Blanton, L. H., Broder, K. R., & Loehr, J.
- Venue
- MMWR. Recommendations and Reports
- Published
- 2024-08-29
- Volume
- 73
- Issue
- 5
- Pages
- 1-25
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- OpenAlex
- W4401910138
- Cited by
- 259
- References
- 90
- FWCI
- 65.89
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.